Reconoce y pon en práctica el acompañamiento como parte esencial del proceso de atención integral en pacientes pediátricos”

Las enfermedades hematológicas se constituyen en distintas patologías con un gran número de padecimientos con características particulares y un comportamiento diferente entre sí. Por esta razón, en pediatría, se deben considerar distintos aspectos para garantizar los cuidados adecuados al paciente. En la actualidad se toman en cuenta los factores psicoafectivos del niño y no solo los biológicos, al momento de elaborar un tratamiento y brindar cuidados.  

De esta forma, más allá de brindarle al estudiante los aspectos teóricos de este tipo de patologías, esta Postgraduate diploma en Nursing Care of the Pediatric Patient with Malignant Hematologic Pathology ayudará al estudiante a comprender y reconocer la vulnerabilidad de los pacientes y sus familiares, siguiendo un principio ético para un cuidado óptimo y humano. Aun así, también se abordarán aspectos relativos a la fisiopatología del cáncer hematológico y la morfología de la leucemia.  

Se dedicará un módulo exclusivo a comprender los conocimientos sobre los diferentes tipos de accesos vasculares en pediatría hematológica y la mejor forma de tratarlos. También se describirá los principios generales que deben seguir los enfermeros para administrar fármacos en pediatría.  

El equipo docente reunido para esta Postgraduate diploma es de reconocido prestigio y dispone de una amplia experiencia en unidades de referencia a nivel nacional e internacional en el tratamiento y cuidados de los recién nacidos, niños y adolescentes con enfermedad hematológica.Se cuenta con un programa 100% online que aporta al alumno la facilidad de poder cursarlo cómodamente, donde y cuando quiera. Solo necesitará un dispositivo con acceso a internet para lanzar su carrera un paso más allá. Una modalidad acorde al tiempo actual con todas las garantías para posicionar al enfermero en un sector altamente demandado.

Alcanza los conocimientos y habilidades necesarios para poder desarrollar las actitudes personales y profesionales necesarias para acoger a pacientes pediátricos con enfermedades hematológicas”

Esta Postgraduate diploma en Nursing Care of the Pediatric Patient with Malignant Hematologic Pathology contiene el programa educativo más completo y actualizado del mercado. Las características más destacadas son:  

• El desarrollo de casos prácticos presentados por expertos en Hematología Pediátrica para Enfermería
• Los contenidos gráficos, esquemáticos y eminentemente prácticos con los que está concebido, recogen una información científica y práctica sobre aquellas disciplinas indispensables para el ejercicio profesional
• Los ejercicios prácticos donde realizar el proceso de autoevaluación para mejorar el aprendizaje
• Su especial hincapié en metodologías innovadoras
• Las lecciones teóricas, preguntas al experto, foros de discusión de temas controvertidos y trabajos de reflexión individual
• La disponibilidad de acceso a los contenidos desde cualquier dispositivo fijo o portátil con conexión a internet

Adquiere las competencias necesarias para llevar a cabo la administración de fármacos y los cuidados necesarios en pacientes con enfermedades hematológicas”

El programa incluye, en su cuadro docente, a profesionales del sector que vierten en esta capacitación la experiencia de su trabajo, además de reconocidos especialistas de sociedades de referencia y universidades de prestigio.   

Su contenido multimedia, elaborado con la última tecnología educativa, permitirá al profesional un aprendizaje situado y contextual, es decir, un entorno simulado que proporcionará una capacitación inmersiva programada para entrenarse ante situaciones reales.   

El diseño de este programa se centra en el Aprendizaje Basado en Problemas, mediante el cual el profesional deberá tratar de resolver las distintas situaciones de práctica profesional que se le planteen a lo largo del programa. Para ello, contará con la ayuda de un novedoso sistema de vídeo interactivo realizado por reconocidos expertos.

Comprende la importancia de una valoración integral y continua de las necesidades del niño con una enfermedad hematológica y su familia"

Podrás disponer de toda la información a cualquier hora del día y sin importar donde estés gracias a la modalidad 100% Online"

Ensure that students meet the requirements of nursing applied to pediatric patients with hematological malignancies, a syllabus has been developed whose modules offer a broad perspective of this field of action, allowing the student to learn the most relevant aspects and the classification of the different acute myeloid leukemias in childhood. From module 1, students will see their knowledge broadened, which will enable them to develop professionally, knowing that they can count on the support of a team of experts.

Understands the importance of nutrition and skin care during the treatment of pediatric patients with oncohematologic disease"

Module 1. Malignant Hematologic Pathology in Pediatrics

1.1. Epidemiology and Pathophysiology of Hematologic Cancer in Pediatrics

1.1.1. Epidemiology of Hematologic Cancer in Pediatrics

1.1.1.1. General aspects
1.1.1.2. Acute Lymphoblastic Leukemia
1.1.1.3. Hodgkin's Lymphomas
1.1.1.4. Non-Hodgkin's Lymphoma

1.1.2. Pathophysiology of Cancer in Pediatrics

1.1.2.1. Unlimited Replication Potential
1.1.2.2. Clonal Expansion
1.1.2.3. Aberrant Differentiation
1.1.2.4. Avoidance by Apoptosis

1.2. Standard or Intermediate-Risk B-Cell Acute Lymphoblastic Leukemia (B-ALL) in Pediatrics

1.2.1. Introduction
1.2.2. Clinical symptoms
1.2.3. Diagnosis
1.2.4. Treatment

1.3. High-Risk B-ALL and T-ALL in Pediatrics

1.3.1. High-Risk B-ALL

1.3.1.1. Introduction
1.3.1.2. Clinical symptoms
1.3.1.3. Diagnosis
1.3.1.4. Treatment

1.3.2. LLA-T

1.3.2.1. Introduction
1.3.2.2. Clinical Symptoms
1.3.2.3. Diagnosis
1.3.2.4. Treatment

1.4. Leukemia in Infants (Infantile Leukemia)

1.4.1. Introduction
1.4.2. Chromosomal Alterations
1.4.3. Clinical Characteristics
1.4.4. Therapeutic Approaches
1.4.5. Survival

1.5. Childhood Acute Myeloid Leukemia

1.5.1. Acute Myeloid Leukemias in Pediatrics

1.5.1.1. Association to Syndromes
1.5.1.2. Stratification by Risk Groups

1.5.2. Acute Promyelocytic Leukemia in Pediatrics (ALL or AML L3)

1.5.2.1. Morphological
1.5.2.2. Translocations
1.5.2.3. Characteristic Coagulopathy
1.5.2.4. Treatment
1.5.2.5. Controls

1.6. Others Leukemias and Myelodysplastic Syndromes in Pediatrics

1.6.1. Chronic Myeloid Leukemia

1.6.1.1. Clinical symptoms
1.6.1.2. Treatment

1.6.2. Juvenile Myelomonocytic Leukemia (JMML)

1.6.2.1. Definition
1.6.2.2. Clinical Symptoms
1.6.2.3. Treatment
1.6.2.4. New Therapies

1.6.3. Myelodysplastic Syndromes

1.7. Hodgkin's Lymphoma in Pediatrics

1.7.1. Introduction
1.7.2. Clinical symptoms
1.7.3. Diagnosis and Staging
1.7.4. Treatment
1.7.5. Prognosis

1.8. Non-Hodgkin's Lymphoma in Pediatrics

1.8.1. Introduction
1.8.2. Classification
1.8.3. Clinical symptoms
1.8.4. Diagnosis and Staging
1.8.5. Treatment

1.9. Burkitt Lymphoma

1.9.1. Specific Characteristics
1.9.2. Forms of Presentation
1.9.3. Clinical Symptoms
1.9.4. Diagnosis
1.9.5. Treatment

1.10. Malignant Histiocytosis

1.10.1. Langerhans Cell Histiocytosis (LCH)

1.10.1.1. Clinical Symptoms
1.10.1.2. Diagnosis
1.10.1.3. Treatment

1.10.2. Hemophagocytic Lymphohistiocytosis

1.10.2.1. Diagnosis
1.10.2.2. Treatment 

Module 2. Pharmacological Treatment and Nursing Care of the Child with Hematologic Pathology 

2.1. Central and Peripheral Venous Catheters. Nursing care

2.1.1. Introduction
2.1.2. Choice of Catheter
2.1.3. Peripheral Venous Accesses
2.1.4. Central Venous Access

2.2. The Great Ally: Subcutaneous Reservoir. Most Important Aspects of Care

2.2.1. Introduction
2.2.2. Placement Indications
2.2.3. Advantages and Disadvantages
2.2.4. Implementation.
2.2.5. Withdrawal

2.3. General Principles of Drug Administration in Pediatrics

2.3.1. Safety in the Administration of Drugs in Hematologic Pediatrics
2.3.2. Routes of Administration and Care
2.3.3. Recording of Drug Administration
2.3.4. Main Drugs to Support Treatment

2.4. Most relevant Treatments in Patients with Immunodeficiencies

2.4.1. General Measures
2.4.2. Prophylactic and/or Symptomatic Treatment
2.4.3. Substitution Treatment
2.4.4. Curative Treatment

2.5. Antineoplastic Treatment (I)

2.5.1. Chemotherapy Fundamentals
2.5.2. Erythropoietin Indications
2.5.3. Treatment Response Criteria
2.5.4. Drug Resistance
2.5.5. Forms of Chemotherapy Administration
2.5.6. Interaction of Chemotherapy with Other Drugs
2.5.7. Chemotherapy Regimens
2.5.8. Dose Intensity

2.6. Antineoplastic Treatment (II)

2.6.1. Most Commonly Used Antineoplastic Agents in Pediatric Hematology
2.6.2. Chemoprotective Agents
2.6.3. Short- and Medium-Term Side Effects

2.7. Administration of Antineoplastic Drugs. Most Important Care

2.7.1. General Measures in the Administration of Cytostatics
2.7.2. Risk Prevention in the Administration of Cytostatic Drugs

2.7.2.1. Safety Circuit
2.7.2.2. Drug Reception and Storage
2.7.2.3. Dual Validation of Pharmacological and Non-Pharmacological Measures Prior to Drug Infusion
2.7.2.4. Dual Validation of the Antineoplastic Drug
2.7.2.5. Personal Protective Equipment (EPI)
2.7.2.6. Drug Corroboration at the Bedside

2.7.3. Nursing Care by Route of Administration

2.7.3.1. Nursing Care in Oral Administration
2.7.3.2. Intramuscular Administration Nursing Care
2.7.3.3. Intrathecal Administration Nursing Care
2.7.3.4. Intra-Arterial Administration Nursing Care

2.7.4. Nursing Action in the Avent of a Cytostatic Spill

2.8. Administration of Antineoplastic Drugs. Most Important Care

2.8.1. Agents Irritant Capacity and Toxicity of Antineoplastic Agents
2.8.2. Pre-, During- and Post-Administration Care
2.8.3. Action in Case of Complications

2.9. Hemotherapy Support in Pediatrics. Most Relevant Care

2.9.1. Blood Products

2.9.1.1.1. Whole Blood
2.9.1.2. Red blood Cell Concentrates
2.9.1.3. Platelet Concentrate
2.9.1.4. Fresh Plasma

2.9.2. Irradiation and Washing of Products
2.9.3. Transfusion Indications and Dosage
2.9.4. Request

2.9.4.1. Documentation
2.9.4.2. Crossmatch Sample

2.9.5. Administration of Blood Derivatives
2.9.6. Adverse Reactions
2.9.7. Transfusion Safety

Module 3. Nursing Care of the Child and Adolescent with Severe Hematologic Disease and Their Families

3.1. “Caring with Care" for the Child/Adolescent and His or Her Family

3.1.1. Fragility and Vulnerability

3.1.1.1. Of the People We Care For
3.1.1.2. From Nursing Professionals

3.1.2. Sympathy, Empathy and Compassion

3.1.2.1. Of the People We Care For
3.1.2.2. From Nursing Professionals

3.1.3. Bioethics and Pediatrics

3.1.3.1. Paternalism in Pediatrics
3.1.3.2. The Problem of Autonomy in Minors
3.1.3.3. Assent and Informed Consent for Minors
3.1.3.4. Autonomy in Adolescence and the Mature Child
3.1.3.5. Legal Capacity of the Minor
3.1.3.6. Parental Access to Medical Records
3.1.3.7. The Health Care Ethics Committee (CEA)
3.1.3.8. Nursing As An Ethical Guarantee

3.2. Safety as a Priority in Paediatric

3.2.1. Why and What For?
3.2.2. Professionals Involved
3.2.3. Safety Priorities
3.2.4. Care Based on Scientific Evidence
3.2.5. Safety in the Pediatric Hematology Unit

3.3. Child/Adolescent and Family Reception at the Onset of Severe Hematologic Disease

3.3.1. The Debut of the Child and Adolescent with Severe Hematologic Disease
3.3.2. Care in the Pediatric Emergency Unit
3.3.3. Care in the Hospitalization Unit

3.4. Observation and Active Listening in Pediatric Hematology

3.4.1. Differences between Seeing, Looking and Observing
3.4.2. Objectives of Active Observation
3.4.3. Moments of Observation in Pediatric Hematology

3.4.3.1. Observation of the Child
3.4.3.2. Family Observation

3.4.4. Obstacles and Difficulties

3.5. Assessment and Nursing Diagnosis in Pediatric Hematology

3.5.1. Basis of Nursing Assessment

3.5.1.1. Process, Planned, Systematic, Continuous, Deliberate
3.5.1.2. Valuation Objectives
3.5.1.3. Types of Valuation According to Objectives
3.5.1.4. Overall Appraisal
3.5.1.5. Focused Assessment

3.5.2. Stages of the Nursing Assessment Process

3.5.2.1. Obtaining Results
3.5.2.2. Evaluation of Information
3.5.2.3. Standardized Assessment in Pediatric Hematology

3.5.3. Detection of Problems in Pediatric Hematology
3.5.4. Interdependent Problems in Pediatric Hematology
3.5.5. Most Frequent Nursing Diagnoses in Pediatric Hematology According to the Situation

3.6. Nursing Care in Symptom Management in Pediatric Hematology

3.6.1. General Principles of Symptom
3.6.2. Symptom Assessment
3.6.3. Variable Emotional Attitude
3.6.4. Irritability
3.6.5. Physical Pain
3.6.6. Myelosuppression Derivatives
3.6.7. Anorexia
3.6.8. Nausea and Vomiting
3.6.9. Digestive System
3.6.10. Alopecia
3.6.11. Cushing's Syndrome
3.6.12. Hemorrhagic Cystitis
3.6.13. Pneumonitis
3.6.14. Ocular and Other Sensory Organ Disorders
3.6.15. Neurological Alterations:

3.7. Skin Care in Pediatric Patients with Severe Hematologic Disease

3.7.1. Introduction
3.7.2. General Skin Care

3.7.2.1. Sun Exposure
3.7.2.2. Clothing
3.7.2.3. Hygiene and Hydration
3.7.2.4. Nails
3.7.2.5. Postural Changes

3.7.3. Most Common Alterations. Prevention, Assessment, Treatment

3.7.3.1. Alopecia
3.7.3.2. Hirsutism
3.7.3.3. Exfoliative Dermatitis or Palmoplantar Erythrodysesthesia
3.7.3.4. Pruritus
3.7.3.5. Stretch Marks
3.7.3.6. Ulcerations
3.7.3.7. Perianal and Genital Dermatoses
3.7.3.8. Mucositis
3.7.3.9. Related to Therapeutic Devices

3.8. Feeding in Children with Hematologic Malignancies

3.8.1. Importance of Nutrition in Childhood
3.8.2. Special Needs of the Child with Severe Hematologic Pathology
3.8.3. Side Effects of Treatment in Children With Severe Hematologic Pathology
3.8.4. Adaptation of Diet in Children with Severe Hematologic Pathology
3.8.5. Nutritional Support
3.8.6. Adaptation of the Diet in Complications
3.8.7. Other Combinational Nutritional Therapies
3.8.8. Adapted Recipes/Tips to Make the Meal More Appetizing

3.9. Performance of Diagnostic Tests. Nursing care

3.9.1. Patient and Family Information
3.9.2. Coordination of Professionals
3.9.3. Patient Preparation
3.9.4. Care During the Test
3.9.5. Patient Reception
3.9.6. Specific Care During the Following Hours

3.10. Nursing Consultation of the Pediatric Patient with Non-malignant Hematologic Disease. Specific Care

3.10.1. Introduction
3.10.2. Diagnostic Support
3.10.3. Socio-Family Assessment and Quality of Life
3.10.4. Education Preventive Measures
3.10.5. Adherence to Treatment
3.10.6. Transition to the Adult Unit

3.11. Research in Pediatric Hematology Care

3.11.1. Evidence-Based Nursing (EBN)

3.11.1.1. Pillars of EBE
3.11.1.2. EBE Phases and Models
3.11.1.3. Formulation of Questions
3.11.1.4. Search for Evidence
3.11.1.5. Critical Reading
3.11.1.6. Implementation and Evaluation

3.11.2. Research Methodology
3.11.3. Innovation in Care
3.11.4. Where Are We Headed?

Knows and acquires the necessary competencies to carry out the administration and care of hemotherapy support in children and adolescents"